FDA Import Refusal SCS-2621764-8/11/1 — Boehringer Ingelheim Pharma GmbH & Co. Kg
The FDA refused shipment SCS-2621764-8/11/1 from Boehringer Ingelheim Pharma GmbH & Co. Kg (Germany) on December 9, 2020. The refused product falls under Drugs and Biologics — MELOXICAM (ANTI-INFLAMMATORY, PART II). Cited charge: 72 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- December 9, 2020
- Country
- Germany
- Product Category
- Drugs and Biologics
- Product Code
- 62YQK07 MELOXICAM (ANTI-INFLAMMATORY, PART II)
- Charges
- 72